EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study

Vanessa Pereira, Amanda Cuevas-Sierra iD, Victor de la O iD, Rita Salvado, Inês Barreiros-Mota, Inês Castela, Alexandra Camelo, Inês Brandão, Christophe Espírito Santo iD, Ana Faria iD, Conceição Calhau, Marta P Silvestre iD und 1 weitere

Nutrients · 2025

DOI: 10.3390/nu17142360 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Vanessa Pereira und 12 weiteren Autor:innen. Beteiligte Einrichtung: NOVA Medical School, Faculty of Medical Sciences, NMS, FCM, Nova University of Lisbon, 1169-056 Lisbon, Portugal. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Obesity, Weight Reduction Programs, Weight Loss. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CINTESIS@RISE, Farmodiética S.A.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut microbiota is increasingly recognized as a key modulator in obesity management, influencing host energy balance, lipid metabolism, and inflammatory pathways. With obesity prevalence continuing to rise globally, dietary interventions that promote beneficial microbial shifts are essential for enhancing weight loss outcomes and long-term health.

Objective

This study investigated the effects of the multicomponent Weight Loss Maintenance 3 Phases Program (WLM3P), which integrates caloric restriction, a high-protein low-carbohydrate diet, time-restricted eating (10h TRE), dietary supplementation (prebiotics and phytochemicals), and digital app-based support on gut microbiota composition compared to a standard low-carbohydrate diet (LCD) in adults with obesity. The analysis focused exclusively on the 6-month weight loss period corresponding to Phases 1 and 2 of the WLM3P intervention.

Methods

In this sub-analysis of a randomized controlled trial (ClinicalTrials.gov Identifier: NCT04192357), 58 adults with obesity (BMI 30.0–39.9 kg/m2) were randomized to the WLM3P (n = 29) or LCD (n = 29) groups. Stool samples were collected at baseline and 6 months for 16S rRNA sequencing. Alpha and beta diversity were assessed, and genus-level differential abundance was determined using EdgeR and LEfSe. Associations between microbial taxa and clinical outcomes were evaluated using regression models.

Results

After 6-month, the WLM3P group showed a significant increase in alpha diversity (p = 0.03) and a significant change in beta diversity (p < 0.01), while no significant changes were observed in the LCD group. Differential abundance analysis revealed specific microbial signatures in WLM3P participants, including increased levels of Faecalibacterium. Notably, higher Faecalibacterium abundance was associated with greater reductions in fat mass (kg, %) and visceral adiposity (cm2) in the WLM3P group compared to LCD (p < 0.01).

Conclusions

These findings suggest a potential microbiota-mediated mechanism in weight loss, where Faecalibacterium may enhance fat reduction effectiveness in the context of the WLM3P intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeObesityWeight Reduction ProgramsWeight LossHumansMaleFemaleAdultMiddle AgedFecesCaloric RestrictionDiet, Carbohydrate-RestrictedPrebioticsDietary Supplements

Stichwörter der Autor:innen

Faecalibacteriumdietary interventionsfat mass lossgut microbiotavisceral fat lossweight loss

Substanzen

Prebiotics

Autor:innen und Institutionen

  • NOVA Medical School, Faculty of Medical Sciences, NMS, FCM, Nova University of Lisbon, 1169-056 Lisbon, Portugal.
  • Nutrition Department Farmodiética, Farmodiética, 2785-723 Lisbon, Portugal.
  • Precision Nutrition and Cardiometabolic Health, IMDEA-Alimentación Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI), Universidad Autónoma de Madrid (UAM), Spanish National Rese…
  • Faculty of Health Sciences, International University of La Rioja (UNIR), 26006 Logroño, Spain.
  • Primary Care Research Unit of Salamanca (APISAL), Salamanca Primary Healthcare Management, Castilla y León Regional Health Authority (SACyL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
  • Comprehensive Health Research Center (CHRC), NOVA Medical School, Faculty of Medical Sciences, NMS, FCM, NOVA University Lisbon, 1169-056 Lisbon, Portugal.

ORCID-Profile: Amanda Cuevas-Sierra, Victor de la O, Christophe Espírito Santo, Ana Faria, Marta P Silvestre, André Moreira-Rosário

Förderung

  • CINTESIS@RISE
  • Farmodiética S.A

Zitieren

APA

Pereira, V., Cuevas-Sierra, A., de la O, V., Salvado, R., Barreiros-Mota, I., Castela, I., Camelo, A., Brandão, I., Santo, C. E., Faria, A., Calhau, C., Silvestre, M. P., & Moreira-Rosário, A. (2025). Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study. Nutrients. https://doi.org/10.3390/nu17142360

Vancouver

Pereira V, Cuevas-Sierra A, de la O V, Salvado R, Barreiros-Mota I, Castela I, et al. Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study. Nutrients. 2025. doi:10.3390/nu17142360

BibTeX
@article{Pereira2025,
  author = {Pereira, Vanessa and Cuevas-Sierra, Amanda and de la O, Victor and Salvado, Rita and Barreiros-Mota, Inês and Castela, Inês and Camelo, Alexandra and Brandão, Inês and Santo, Christophe Espírito and Faria, Ana and Calhau, Conceição and Silvestre, Marta P and Moreira-Rosário, André},
  title = {Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17142360}
}
Kostenlos starten →